nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—EDNRB—melanoma	0.635	0.893	CbGaD
MACITENTAN—ALB—Vemurafenib—melanoma	0.0875	0.502	CbGbCtD
MACITENTAN—ALB—melanoma	0.076	0.107	CbGaD
MACITENTAN—CYP3A4—Temozolomide—melanoma	0.05	0.287	CbGbCtD
MACITENTAN—CYP3A4—Vemurafenib—melanoma	0.0274	0.157	CbGbCtD
MACITENTAN—CYP3A4—Docetaxel—melanoma	0.00941	0.054	CbGbCtD
MACITENTAN—Hepatotoxicity—Vemurafenib—melanoma	0.0019	0.0922	CcSEcCtD
MACITENTAN—Hepatotoxicity—Dactinomycin—melanoma	0.00107	0.0521	CcSEcCtD
MACITENTAN—Hepatotoxicity—Carmustine—melanoma	0.001	0.0487	CcSEcCtD
MACITENTAN—Hepatotoxicity—Temozolomide—melanoma	0.00097	0.0471	CcSEcCtD
MACITENTAN—Infestation—Vemurafenib—melanoma	0.00082	0.0398	CcSEcCtD
MACITENTAN—Infestation NOS—Vemurafenib—melanoma	0.00082	0.0398	CcSEcCtD
MACITENTAN—Angiopathy—Vemurafenib—melanoma	0.000668	0.0324	CcSEcCtD
MACITENTAN—Hepatotoxicity—Docetaxel—melanoma	0.000645	0.0313	CcSEcCtD
MACITENTAN—Infection—Vemurafenib—melanoma	0.000519	0.0252	CcSEcCtD
MACITENTAN—Nervous system disorder—Vemurafenib—melanoma	0.000513	0.0249	CcSEcCtD
MACITENTAN—Hypotension—Vemurafenib—melanoma	0.000489	0.0237	CcSEcCtD
MACITENTAN—Fluid retention—Docetaxel—melanoma	0.000473	0.023	CcSEcCtD
MACITENTAN—Bronchitis—Temozolomide—melanoma	0.000452	0.0219	CcSEcCtD
MACITENTAN—Urinary tract infection—Carmustine—melanoma	0.000421	0.0205	CcSEcCtD
MACITENTAN—Infestation NOS—Temozolomide—melanoma	0.000419	0.0203	CcSEcCtD
MACITENTAN—Infestation—Temozolomide—melanoma	0.000419	0.0203	CcSEcCtD
MACITENTAN—Pharyngitis—Dactinomycin—melanoma	0.000413	0.02	CcSEcCtD
MACITENTAN—Urinary tract infection—Temozolomide—melanoma	0.000407	0.0198	CcSEcCtD
MACITENTAN—Pharyngitis—Temozolomide—melanoma	0.000373	0.0181	CcSEcCtD
MACITENTAN—Anaemia—Bleomycin—melanoma	0.000359	0.0174	CcSEcCtD
MACITENTAN—Angiopathy—Temozolomide—melanoma	0.000341	0.0166	CcSEcCtD
MACITENTAN—Anaemia—Dactinomycin—melanoma	0.000335	0.0162	CcSEcCtD
MACITENTAN—Headache—Vemurafenib—melanoma	0.000328	0.0159	CcSEcCtD
MACITENTAN—Nasopharyngitis—Docetaxel—melanoma	0.000323	0.0157	CcSEcCtD
MACITENTAN—Oedema—Bleomycin—melanoma	0.000317	0.0154	CcSEcCtD
MACITENTAN—Infection—Bleomycin—melanoma	0.000315	0.0153	CcSEcCtD
MACITENTAN—Anaemia—Carmustine—melanoma	0.000313	0.0152	CcSEcCtD
MACITENTAN—Anaemia—Temozolomide—melanoma	0.000303	0.0147	CcSEcCtD
MACITENTAN—Hypotension—Bleomycin—melanoma	0.000296	0.0144	CcSEcCtD
MACITENTAN—Oedema—Dactinomycin—melanoma	0.000295	0.0143	CcSEcCtD
MACITENTAN—Infection—Dactinomycin—melanoma	0.000293	0.0143	CcSEcCtD
MACITENTAN—Infestation—Docetaxel—melanoma	0.000279	0.0135	CcSEcCtD
MACITENTAN—Infestation NOS—Docetaxel—melanoma	0.000279	0.0135	CcSEcCtD
MACITENTAN—Oedema—Carmustine—melanoma	0.000277	0.0134	CcSEcCtD
MACITENTAN—Infection—Carmustine—melanoma	0.000275	0.0133	CcSEcCtD
MACITENTAN—Oedema—Temozolomide—melanoma	0.000267	0.013	CcSEcCtD
MACITENTAN—Infection—Temozolomide—melanoma	0.000265	0.0129	CcSEcCtD
MACITENTAN—Nervous system disorder—Temozolomide—melanoma	0.000262	0.0127	CcSEcCtD
MACITENTAN—Hypotension—Carmustine—melanoma	0.000258	0.0125	CcSEcCtD
MACITENTAN—Pharyngitis—Docetaxel—melanoma	0.000248	0.0121	CcSEcCtD
MACITENTAN—Angiopathy—Docetaxel—melanoma	0.000227	0.011	CcSEcCtD
MACITENTAN—Anaemia—Docetaxel—melanoma	0.000201	0.00977	CcSEcCtD
MACITENTAN—Oedema—Docetaxel—melanoma	0.000178	0.00863	CcSEcCtD
MACITENTAN—Infection—Docetaxel—melanoma	0.000177	0.00857	CcSEcCtD
MACITENTAN—Nervous system disorder—Docetaxel—melanoma	0.000174	0.00846	CcSEcCtD
MACITENTAN—Headache—Carmustine—melanoma	0.000173	0.00841	CcSEcCtD
MACITENTAN—Headache—Temozolomide—melanoma	0.000167	0.00813	CcSEcCtD
MACITENTAN—Hypotension—Docetaxel—melanoma	0.000166	0.00806	CcSEcCtD
MACITENTAN—Headache—Docetaxel—melanoma	0.000111	0.00541	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—EGFR—melanoma	1.99e-05	0.000212	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.98e-05	0.000211	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ITGAV—melanoma	1.96e-05	0.000209	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT3—melanoma	1.96e-05	0.000209	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SPP1—melanoma	1.96e-05	0.000208	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC6A11—melanoma	1.95e-05	0.000208	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIP4K2A—melanoma	1.95e-05	0.000208	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAP2K2—melanoma	1.95e-05	0.000208	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL8—melanoma	1.95e-05	0.000207	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAP2K1—melanoma	1.93e-05	0.000206	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CD—melanoma	1.92e-05	0.000204	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IFNA2—melanoma	1.92e-05	0.000204	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	1.91e-05	0.000203	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CA—melanoma	1.9e-05	0.000202	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MTAP—melanoma	1.9e-05	0.000202	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—KRAS—melanoma	1.88e-05	0.0002	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PLCB4—melanoma	1.87e-05	0.000199	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—melanoma	1.86e-05	0.000198	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.86e-05	0.000198	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TERT—melanoma	1.85e-05	0.000197	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RAC1—melanoma	1.85e-05	0.000197	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FGF2—melanoma	1.84e-05	0.000196	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	1.83e-05	0.000195	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	1.8e-05	0.000192	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ITGB1—melanoma	1.78e-05	0.00019	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HIF1A—melanoma	1.77e-05	0.000189	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC6A11—melanoma	1.75e-05	0.000187	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIP4K2A—melanoma	1.75e-05	0.000187	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ACER3—melanoma	1.74e-05	0.000185	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CA—melanoma	1.73e-05	0.000184	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MDM2—melanoma	1.72e-05	0.000183	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MTAP—melanoma	1.71e-05	0.000182	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KDR—melanoma	1.7e-05	0.000181	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ERBB2—melanoma	1.7e-05	0.00018	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LUM—melanoma	1.69e-05	0.00018	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PHGDH—melanoma	1.69e-05	0.00018	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CB—melanoma	1.67e-05	0.000178	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.67e-05	0.000178	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HPSE—melanoma	1.66e-05	0.000177	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	1.65e-05	0.000176	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FN1—melanoma	1.63e-05	0.000174	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HGF—melanoma	1.63e-05	0.000174	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CUBN—melanoma	1.63e-05	0.000174	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CSF2—melanoma	1.61e-05	0.000172	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL8—melanoma	1.61e-05	0.000171	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NOTCH1—melanoma	1.6e-05	0.00017	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HRAS—melanoma	1.6e-05	0.00017	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—UGT2B10—melanoma	1.59e-05	0.00017	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SDHD—melanoma	1.58e-05	0.000168	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—BSG—melanoma	1.58e-05	0.000168	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CSPG4—melanoma	1.58e-05	0.000168	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN1B—melanoma	1.57e-05	0.000167	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CD80—melanoma	1.57e-05	0.000167	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—APC—melanoma	1.56e-05	0.000166	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KIT—melanoma	1.56e-05	0.000166	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CG—melanoma	1.56e-05	0.000166	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—NRAS—melanoma	1.56e-05	0.000166	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AKT1—melanoma	1.55e-05	0.000165	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ITGB3—melanoma	1.55e-05	0.000165	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PRKCA—melanoma	1.55e-05	0.000165	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGF—melanoma	1.54e-05	0.000164	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CASP3—melanoma	1.54e-05	0.000164	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—melanoma	1.54e-05	0.000164	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—melanoma	1.53e-05	0.000163	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPAM—melanoma	1.53e-05	0.000162	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PHGDH—melanoma	1.52e-05	0.000162	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LUM—melanoma	1.52e-05	0.000162	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCND1—melanoma	1.5e-05	0.000159	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK3—melanoma	1.5e-05	0.000159	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HPSE—melanoma	1.49e-05	0.000159	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CTNNB1—melanoma	1.48e-05	0.000158	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HS3ST5—melanoma	1.48e-05	0.000158	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BRAF—melanoma	1.47e-05	0.000156	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CUBN—melanoma	1.46e-05	0.000156	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.45e-05	0.000155	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MMP9—melanoma	1.45e-05	0.000155	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN1A—melanoma	1.45e-05	0.000154	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTEN—melanoma	1.45e-05	0.000154	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NFKB1—melanoma	1.44e-05	0.000153	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAC1—melanoma	1.43e-05	0.000153	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF1—melanoma	1.43e-05	0.000152	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK1—melanoma	1.42e-05	0.000152	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EGFR—melanoma	1.42e-05	0.000152	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CSPG4—melanoma	1.41e-05	0.000151	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SDHD—melanoma	1.41e-05	0.000151	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—BSG—melanoma	1.41e-05	0.000151	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AKT1—melanoma	1.41e-05	0.00015	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.41e-05	0.00015	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MMP1—melanoma	1.39e-05	0.000148	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAP2K1—melanoma	1.38e-05	0.000147	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CD—melanoma	1.37e-05	0.000146	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPAM—melanoma	1.37e-05	0.000146	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CDK2—melanoma	1.36e-05	0.000145	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CA—melanoma	1.36e-05	0.000145	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—KRAS—melanoma	1.34e-05	0.000143	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.33e-05	0.000142	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FGF2—melanoma	1.32e-05	0.00014	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—melanoma	1.31e-05	0.000139	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PLA2G6—melanoma	1.3e-05	0.000138	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STAT3—melanoma	1.29e-05	0.000138	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NRAS—melanoma	1.29e-05	0.000137	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—FN1—melanoma	1.27e-05	0.000135	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.27e-05	0.000135	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NOS2—melanoma	1.25e-05	0.000133	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CA—melanoma	1.24e-05	0.000132	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK3—melanoma	1.24e-05	0.000131	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MDM2—melanoma	1.23e-05	0.000131	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ERBB2—melanoma	1.21e-05	0.000129	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CG—melanoma	1.21e-05	0.000129	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MYC—melanoma	1.2e-05	0.000128	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—EGF—melanoma	1.2e-05	0.000127	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CB—melanoma	1.2e-05	0.000127	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK1—melanoma	1.18e-05	0.000125	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—melanoma	1.18e-05	0.000125	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—VCAN—melanoma	1.17e-05	0.000124	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PLA2G6—melanoma	1.16e-05	0.000124	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL8—melanoma	1.15e-05	0.000122	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HRAS—melanoma	1.14e-05	0.000122	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN1B—melanoma	1.12e-05	0.00012	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PLCB4—melanoma	1.12e-05	0.000119	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AKT1—melanoma	1.11e-05	0.000118	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KRAS—melanoma	1.11e-05	0.000118	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF1—melanoma	1.11e-05	0.000118	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.1e-05	0.000117	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CASP3—melanoma	1.1e-05	0.000117	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—melanoma	1.1e-05	0.000117	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.1e-05	0.000117	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—melanoma	1.09e-05	0.000116	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCND1—melanoma	1.07e-05	0.000114	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CD—melanoma	1.07e-05	0.000113	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.06e-05	0.000113	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CTNNB1—melanoma	1.06e-05	0.000113	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC6A11—melanoma	1.05e-05	0.000112	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIP4K2A—melanoma	1.05e-05	0.000112	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—VCAN—melanoma	1.05e-05	0.000111	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—melanoma	1.04e-05	0.000111	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN1A—melanoma	1.04e-05	0.00011	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTEN—melanoma	1.03e-05	0.00011	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NFKB1—melanoma	1.03e-05	0.00011	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MTAP—melanoma	1.03e-05	0.000109	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CA—melanoma	1.02e-05	0.000109	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AKT1—melanoma	1.01e-05	0.000107	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.9e-06	0.000105	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—melanoma	9.87e-06	0.000105	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP17A1—melanoma	9.83e-06	0.000105	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.7e-06	0.000103	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.56e-06	0.000102	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HRAS—melanoma	9.44e-06	0.0001	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—melanoma	9.35e-06	9.95e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GNA11—melanoma	9.28e-06	9.88e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CB—melanoma	9.28e-06	9.88e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—STAT3—melanoma	9.25e-06	9.85e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NRAS—melanoma	9.23e-06	9.83e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LUM—melanoma	9.15e-06	9.74e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PHGDH—melanoma	9.15e-06	9.74e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—FASN—melanoma	9.09e-06	9.67e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—melanoma	9.03e-06	9.61e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HPSE—melanoma	8.97e-06	9.55e-05	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	8.97e-06	9.55e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC5A5—melanoma	8.94e-06	9.51e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK3—melanoma	8.84e-06	9.41e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP17A1—melanoma	8.83e-06	9.39e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CUBN—melanoma	8.8e-06	9.37e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.7e-06	9.27e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GNAQ—melanoma	8.63e-06	9.19e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CD44—melanoma	8.63e-06	9.19e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MYC—melanoma	8.6e-06	9.15e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.59e-06	9.15e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—melanoma	8.53e-06	9.08e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SDHD—melanoma	8.5e-06	9.05e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—BSG—melanoma	8.5e-06	9.05e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CSPG4—melanoma	8.5e-06	9.05e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.45e-06	9e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK1—melanoma	8.41e-06	8.95e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—melanoma	8.41e-06	8.95e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.37e-06	8.91e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GNA11—melanoma	8.33e-06	8.87e-05	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKT1—melanoma	8.33e-06	8.87e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1B1—melanoma	8.27e-06	8.81e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPAM—melanoma	8.24e-06	8.77e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—FASN—melanoma	8.16e-06	8.68e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC5A5—melanoma	8.02e-06	8.54e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KRAS—melanoma	7.94e-06	8.46e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CD44—melanoma	7.75e-06	8.25e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GNAQ—melanoma	7.75e-06	8.25e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.59e-06	8.08e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.52e-06	8e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1B1—melanoma	7.43e-06	7.91e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.3e-06	7.77e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CA—melanoma	7.3e-06	7.77e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—melanoma	7.25e-06	7.71e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NRAS—melanoma	7.16e-06	7.62e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—melanoma	7.06e-06	7.52e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PLA2G6—melanoma	7e-06	7.45e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK3—melanoma	6.85e-06	7.3e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ABCB1—melanoma	6.81e-06	7.25e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HRAS—melanoma	6.75e-06	7.19e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.56e-06	6.98e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK1—melanoma	6.52e-06	6.94e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—melanoma	6.46e-06	6.88e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—VCAN—melanoma	6.29e-06	6.7e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PRKCA—melanoma	6.27e-06	6.68e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ERCC2—melanoma	6.22e-06	6.62e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KRAS—melanoma	6.16e-06	6.56e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ABCB1—melanoma	6.12e-06	6.51e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKT1—melanoma	5.96e-06	6.35e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CA—melanoma	5.66e-06	6.02e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PRKCA—melanoma	5.63e-06	5.99e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ERCC2—melanoma	5.58e-06	5.94e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—melanoma	5.47e-06	5.83e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP17A1—melanoma	5.31e-06	5.65e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HRAS—melanoma	5.24e-06	5.57e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.15e-06	5.48e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GNA11—melanoma	5.01e-06	5.33e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CG—melanoma	4.91e-06	5.23e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—FASN—melanoma	4.9e-06	5.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A5—melanoma	4.82e-06	5.14e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARG—melanoma	4.74e-06	5.05e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GNAQ—melanoma	4.66e-06	4.96e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CD44—melanoma	4.66e-06	4.96e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.62e-06	4.92e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT1—melanoma	4.62e-06	4.92e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1B1—melanoma	4.47e-06	4.76e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CG—melanoma	4.41e-06	4.69e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CD—melanoma	4.32e-06	4.6e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARG—melanoma	4.26e-06	4.53e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CD—melanoma	3.88e-06	4.13e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALB—melanoma	3.83e-06	4.07e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CB—melanoma	3.76e-06	4.01e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—melanoma	3.73e-06	3.97e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ABCB1—melanoma	3.68e-06	3.92e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PRKCA—melanoma	3.39e-06	3.6e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CB—melanoma	3.38e-06	3.6e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ERCC2—melanoma	3.36e-06	3.57e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—melanoma	3.35e-06	3.56e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTEN—melanoma	3.25e-06	3.46e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTEN—melanoma	2.92e-06	3.11e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CG—melanoma	2.65e-06	2.82e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARG—melanoma	2.56e-06	2.72e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CD—melanoma	2.33e-06	2.48e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALB—melanoma	2.3e-06	2.45e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CA—melanoma	2.29e-06	2.44e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CA—melanoma	2.06e-06	2.19e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CB—melanoma	2.03e-06	2.16e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—melanoma	2.01e-06	2.14e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKT1—melanoma	1.87e-06	2e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTEN—melanoma	1.76e-06	1.87e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKT1—melanoma	1.68e-06	1.79e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CA—melanoma	1.24e-06	1.32e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKT1—melanoma	1.01e-06	1.08e-05	CbGpPWpGaD
